N. Aliyeva Et Al. , "FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS," ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.976-977, 2022
Aliyeva, N. Et Al. 2022. FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS. ANNALS OF THE RHEUMATIC DISEASES , vol.81 , 976-977.
Aliyeva, N., Sari, S., Amikishiyev, S., Dulundu, B. C. Y., Suleymanova, V., Telli, P., ... Yalcinkaya, Y.(2022). FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS. ANNALS OF THE RHEUMATIC DISEASES , vol.81, 976-977.
Aliyeva, N. Et Al. "FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS," ANNALS OF THE RHEUMATIC DISEASES , vol.81, 976-977, 2022
Aliyeva, N. Et Al. "FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.976-977, 2022
Aliyeva, N. Et Al. (2022) . "FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS." ANNALS OF THE RHEUMATIC DISEASES , vol.81, pp.976-977.
@article{article, author={N. Aliyeva Et Al. }, title={FAVOURABLE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER USING BIOLOGIC AGENTS}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2022, pages={976-977} }